The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence
There are no commercially available vaccines against human protozoan parasitic diseases, despite the success of vaccination-induced long-term protection against infectious diseases. East Coast fever, caused by the protist Theileria parva, kills one million cattle each year in sub-Saharan Africa, and...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Journal Article |
| Lenguaje: | Inglés |
| Publicado: |
Springer
2015
|
| Materias: | |
| Acceso en línea: | https://hdl.handle.net/10568/69467 |
| _version_ | 1855513714010095616 |
|---|---|
| author | Norling, M. Bishop, Richard P. Pelle, Roger Weihong Qi Henson, S. Drábek, E.F. Tretina, Kyle Odongo, D. Mwaura, S. Njoroge, T. Bongcam-Rudloff, E. Daubenberger, C.A. Silva, Joana C. |
| author_browse | Bishop, Richard P. Bongcam-Rudloff, E. Daubenberger, C.A. Drábek, E.F. Henson, S. Mwaura, S. Njoroge, T. Norling, M. Odongo, D. Pelle, Roger Silva, Joana C. Tretina, Kyle Weihong Qi |
| author_facet | Norling, M. Bishop, Richard P. Pelle, Roger Weihong Qi Henson, S. Drábek, E.F. Tretina, Kyle Odongo, D. Mwaura, S. Njoroge, T. Bongcam-Rudloff, E. Daubenberger, C.A. Silva, Joana C. |
| author_sort | Norling, M. |
| collection | Repository of Agricultural Research Outputs (CGSpace) |
| description | There are no commercially available vaccines against human protozoan parasitic diseases, despite the success of vaccination-induced long-term protection against infectious diseases. East Coast fever, caused by the protist Theileria parva, kills one million cattle each year in sub-Saharan Africa, and contributes significantly to hunger and poverty in the region. A highly effective, live, multi-isolate vaccine against T. parva exists, but its component isolates have not been characterized. Here we sequence and compare the three component T. parva stocks within this vaccine, the Muguga Cocktail, namely Muguga, Kiambu5 and Serengeti-transformed, aiming to identify genomic features that contribute to vaccine efficacy. We find that Serengeti-transformed, originally isolated from the wildlife carrier, the African Cape buffalo, is remarkably and unexpectedly similar to the Muguga isolate. The 420 detectable non-synonymous SNPs were distributed among only 53 genes, primarily subtelomeric antigens and antigenic families. The Kiambu5 isolate is considerably more divergent, with close to 40,000 SNPs relative to Muguga, including >8,500 non-synonymous mutations distributed among >1,700 (42.5 %) of the predicted genes. These genetic markers of the component stocks can be used to characterize the composition of new batches of the Muguga Cocktail. Differences among these three isolates, while extensive, represent only a small proportion of the genetic variation in the entire species. Given the efficacy of the Muguga Cocktail in inducing long-lasting protection against infections in the field, our results suggest that whole-organism vaccines against parasitic diseases can be highly efficacious despite considerable genome-wide differences relative to the isolates against which they protect. |
| format | Journal Article |
| id | CGSpace69467 |
| institution | CGIAR Consortium |
| language | Inglés |
| publishDate | 2015 |
| publishDateRange | 2015 |
| publishDateSort | 2015 |
| publisher | Springer |
| publisherStr | Springer |
| record_format | dspace |
| spelling | CGSpace694672023-12-08T19:36:04Z The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence Norling, M. Bishop, Richard P. Pelle, Roger Weihong Qi Henson, S. Drábek, E.F. Tretina, Kyle Odongo, D. Mwaura, S. Njoroge, T. Bongcam-Rudloff, E. Daubenberger, C.A. Silva, Joana C. animal diseases genetics biotechnology There are no commercially available vaccines against human protozoan parasitic diseases, despite the success of vaccination-induced long-term protection against infectious diseases. East Coast fever, caused by the protist Theileria parva, kills one million cattle each year in sub-Saharan Africa, and contributes significantly to hunger and poverty in the region. A highly effective, live, multi-isolate vaccine against T. parva exists, but its component isolates have not been characterized. Here we sequence and compare the three component T. parva stocks within this vaccine, the Muguga Cocktail, namely Muguga, Kiambu5 and Serengeti-transformed, aiming to identify genomic features that contribute to vaccine efficacy. We find that Serengeti-transformed, originally isolated from the wildlife carrier, the African Cape buffalo, is remarkably and unexpectedly similar to the Muguga isolate. The 420 detectable non-synonymous SNPs were distributed among only 53 genes, primarily subtelomeric antigens and antigenic families. The Kiambu5 isolate is considerably more divergent, with close to 40,000 SNPs relative to Muguga, including >8,500 non-synonymous mutations distributed among >1,700 (42.5 %) of the predicted genes. These genetic markers of the component stocks can be used to characterize the composition of new batches of the Muguga Cocktail. Differences among these three isolates, while extensive, represent only a small proportion of the genetic variation in the entire species. Given the efficacy of the Muguga Cocktail in inducing long-lasting protection against infections in the field, our results suggest that whole-organism vaccines against parasitic diseases can be highly efficacious despite considerable genome-wide differences relative to the isolates against which they protect. 2015-12 2016-01-05T17:41:12Z 2016-01-05T17:41:12Z Journal Article https://hdl.handle.net/10568/69467 en Open Access Springer Norling, M., Bishop, R.P., Pelle, R., Weihong Qi, Henson, S., Drábek, E.F., Tretina, K., Odongo, D., Mwaura, S., Njoroge, T., Bongcam-Rudloff, E., Daubenberger, C.A. and Silva, J.C. 2016. The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence. BMC Genomics 16:729. |
| spellingShingle | animal diseases genetics biotechnology Norling, M. Bishop, Richard P. Pelle, Roger Weihong Qi Henson, S. Drábek, E.F. Tretina, Kyle Odongo, D. Mwaura, S. Njoroge, T. Bongcam-Rudloff, E. Daubenberger, C.A. Silva, Joana C. The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
| title | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
| title_full | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
| title_fullStr | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
| title_full_unstemmed | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
| title_short | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
| title_sort | genomes of three stocks comprising the most widely utilized live sporozoite theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
| topic | animal diseases genetics biotechnology |
| url | https://hdl.handle.net/10568/69467 |
| work_keys_str_mv | AT norlingm thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT bishoprichardp thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT pelleroger thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT weihongqi thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT hensons thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT drabekef thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT tretinakyle thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT odongod thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT mwauras thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT njoroget thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT bongcamrudloffe thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT daubenbergerca thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT silvajoanac thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT norlingm genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT bishoprichardp genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT pelleroger genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT weihongqi genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT hensons genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT drabekef genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT tretinakyle genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT odongod genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT mwauras genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT njoroget genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT bongcamrudloffe genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT daubenbergerca genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT silvajoanac genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence |